Felodipine Extended-Release Tablets Industry Research Report 2025

Summary

According to APO Research, the global Felodipine Extended-Release Tablets market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Felodipine Extended-Release Tablets is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Felodipine Extended-Release Tablets include By-Health, CSPC, Zhejiang Cheng Yi Pharmaceutical, Watsons, Schiff, Pfizer, Movefree, KAL and Doppelherz, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Felodipine Extended-Release Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Extended-Release Tablets.

The report will help the Felodipine Extended-Release Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Felodipine Extended-Release Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Felodipine Extended-Release Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Felodipine Extended-Release Tablets Segment by Company

By-Health
CSPC
Zhejiang Cheng Yi Pharmaceutical
Watsons
Schiff
Pfizer
Movefree
KAL
Doppelherz
Blackmores
AdvaCare
Felodipine Extended-Release Tablets Segment by Type

Tablets
Capsules
Felodipine Extended-Release Tablets Segment by Application

Hospital
Clinic
Pharmacy
Felodipine Extended-Release Tablets Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Felodipine Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Extended-Release Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Felodipine Extended-Release Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Felodipine Extended-Release Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Felodipine Extended-Release Tablets Market Size (2020-2031)
2.2.2 Global Felodipine Extended-Release Tablets Sales (2020-2031)
2.2.3 Global Felodipine Extended-Release Tablets Market Average Price (2020-2031)
2.3 Felodipine Extended-Release Tablets by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Tablets
2.3.3 Capsules
2.4 Felodipine Extended-Release Tablets by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
3.1 Global Felodipine Extended-Release Tablets Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Felodipine Extended-Release Tablets Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Felodipine Extended-Release Tablets Revenue of Manufacturers (2020-2025)
3.4 Global Felodipine Extended-Release Tablets Average Price by Manufacturers (2020-2025)
3.5 Global Felodipine Extended-Release Tablets Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Felodipine Extended-Release Tablets, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Felodipine Extended-Release Tablets, Product Type & Application
3.8 Global Manufacturers of Felodipine Extended-Release Tablets, Established Date
3.9 Global Felodipine Extended-Release Tablets Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 By-Health
4.1.1 By-Health Company Information
4.1.2 By-Health Business Overview
4.1.3 By-Health Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.1.4 By-Health Felodipine Extended-Release Tablets Product Portfolio
4.1.5 By-Health Recent Developments
4.2 CSPC
4.2.1 CSPC Company Information
4.2.2 CSPC Business Overview
4.2.3 CSPC Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.2.4 CSPC Felodipine Extended-Release Tablets Product Portfolio
4.2.5 CSPC Recent Developments
4.3 Zhejiang Cheng Yi Pharmaceutical
4.3.1 Zhejiang Cheng Yi Pharmaceutical Company Information
4.3.2 Zhejiang Cheng Yi Pharmaceutical Business Overview
4.3.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio
4.3.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments
4.4 Watsons
4.4.1 Watsons Company Information
4.4.2 Watsons Business Overview
4.4.3 Watsons Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Watsons Felodipine Extended-Release Tablets Product Portfolio
4.4.5 Watsons Recent Developments
4.5 Schiff
4.5.1 Schiff Company Information
4.5.2 Schiff Business Overview
4.5.3 Schiff Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Schiff Felodipine Extended-Release Tablets Product Portfolio
4.5.5 Schiff Recent Developments
4.6 Pfizer
4.6.1 Pfizer Company Information
4.6.2 Pfizer Business Overview
4.6.3 Pfizer Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio
4.6.5 Pfizer Recent Developments
4.7 Movefree
4.7.1 Movefree Company Information
4.7.2 Movefree Business Overview
4.7.3 Movefree Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Movefree Felodipine Extended-Release Tablets Product Portfolio
4.7.5 Movefree Recent Developments
4.8 KAL
4.8.1 KAL Company Information
4.8.2 KAL Business Overview
4.8.3 KAL Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio
4.8.5 KAL Recent Developments
4.9 Doppelherz
4.9.1 Doppelherz Company Information
4.9.2 Doppelherz Business Overview
4.9.3 Doppelherz Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio
4.9.5 Doppelherz Recent Developments
4.10 Blackmores
4.10.1 Blackmores Company Information
4.10.2 Blackmores Business Overview
4.10.3 Blackmores Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio
4.10.5 Blackmores Recent Developments
4.11 AdvaCare
4.11.1 AdvaCare Company Information
4.11.2 AdvaCare Business Overview
4.11.3 AdvaCare Felodipine Extended-Release Tablets Sales, Revenue and Gross Margin (2020-2025)
4.11.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio
4.11.5 AdvaCare Recent Developments
5 Global Felodipine Extended-Release Tablets Market Scenario by Region
5.1 Global Felodipine Extended-Release Tablets Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Felodipine Extended-Release Tablets Sales by Region: 2020-2031
5.2.1 Global Felodipine Extended-Release Tablets Sales by Region: 2020-2025
5.2.2 Global Felodipine Extended-Release Tablets Sales by Region: 2026-2031
5.3 Global Felodipine Extended-Release Tablets Revenue by Region: 2020-2031
5.3.1 Global Felodipine Extended-Release Tablets Revenue by Region: 2020-2025
5.3.2 Global Felodipine Extended-Release Tablets Revenue by Region: 2026-2031
5.4 North America Felodipine Extended-Release Tablets Market Facts & Figures by Country
5.4.1 North America Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Felodipine Extended-Release Tablets Sales by Country (2020-2031)
5.4.3 North America Felodipine Extended-Release Tablets Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Felodipine Extended-Release Tablets Market Facts & Figures by Country
5.5.1 Europe Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Felodipine Extended-Release Tablets Sales by Country (2020-2031)
5.5.3 Europe Felodipine Extended-Release Tablets Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Felodipine Extended-Release Tablets Market Facts & Figures by Country
5.6.1 Asia Pacific Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Felodipine Extended-Release Tablets Sales by Country (2020-2031)
5.6.3 Asia Pacific Felodipine Extended-Release Tablets Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Felodipine Extended-Release Tablets Market Facts & Figures by Country
5.7.1 South America Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Felodipine Extended-Release Tablets Sales by Country (2020-2031)
5.7.3 South America Felodipine Extended-Release Tablets Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Felodipine Extended-Release Tablets Market Facts & Figures by Country
5.8.1 Middle East and Africa Felodipine Extended-Release Tablets Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Felodipine Extended-Release Tablets Sales by Country (2020-2031)
5.8.3 Middle East and Africa Felodipine Extended-Release Tablets Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Felodipine Extended-Release Tablets Sales by Type (2020-2031)
6.1.1 Global Felodipine Extended-Release Tablets Sales by Type (2020-2031) & (K Units)
6.1.2 Global Felodipine Extended-Release Tablets Sales Market Share by Type (2020-2031)
6.2 Global Felodipine Extended-Release Tablets Revenue by Type (2020-2031)
6.2.1 Global Felodipine Extended-Release Tablets Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Type (2020-2031)
6.3 Global Felodipine Extended-Release Tablets Price by Type (2020-2031)
7 Segment by Application
7.1 Global Felodipine Extended-Release Tablets Sales by Application (2020-2031)
7.1.1 Global Felodipine Extended-Release Tablets Sales by Application (2020-2031) & (K Units)
7.1.2 Global Felodipine Extended-Release Tablets Sales Market Share by Application (2020-2031)
7.2 Global Felodipine Extended-Release Tablets Revenue by Application (2020-2031)
7.2.1 Global Felodipine Extended-Release Tablets Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Felodipine Extended-Release Tablets Revenue Market Share by Application (2020-2031)
7.3 Global Felodipine Extended-Release Tablets Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Felodipine Extended-Release Tablets Value Chain Analysis
8.1.1 Felodipine Extended-Release Tablets Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Felodipine Extended-Release Tablets Production Mode & Process
8.2 Felodipine Extended-Release Tablets Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Felodipine Extended-Release Tablets Distributors
8.2.3 Felodipine Extended-Release Tablets Customers
9 Global Felodipine Extended-Release Tablets Analyzing Market Dynamics
9.1 Felodipine Extended-Release Tablets Industry Trends
9.2 Felodipine Extended-Release Tablets Industry Drivers
9.3 Felodipine Extended-Release Tablets Industry Opportunities and Challenges
9.4 Felodipine Extended-Release Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings